substance use Archives - Alliance for Connected Care

Journal of Substance Use and Addiction Treatment: Feasibility and Acceptability of the Delivery of a Group Telehealth Intervention for Patients Receiving Buprenorphine for Opioid Use Disorder

Journal of Substance Use and Addiction Treatment: Feasibility and Acceptability of the Delivery of a Group Telehealth Intervention for Patients Receiving Buprenorphine for Opioid Use Disorder Patients receiving buprenorphine treatment for opioid use disorder (OUD), their support persons, and clinic staff were interviewed about their perceptions of a novel group telehealth intervention for support [...]

pbrown2025-05-05T16:09:33-04:00January 23rd, 2025|

Departments of Labor, HHS, Treasury: Report to Congress on the Mental Health Parity and Addiction Equity Act

Departments of Labor, HHS, Treasury: Report to Congress on the Mental Health Parity and Addiction Equity Act The Departments of Labor, HHS, and Treasury issued the 2024 Report to Congress on the Mental Health Parity and Addiction Equity Act enforcement and implementation, which highlighted the ongoing efforts of the Departments to strengthen and enforce [...]

pbrown2025-05-05T15:55:54-04:00January 17th, 2025|

Concord Monitor: Telehealth Prescriptions Should be Available for More Mental Health and Substance Use Patients

Concord Monitor: Telehealth Prescriptions Should be Available for More Mental Health and Substance Use Patients The New Hampshire Commission to Study Telehealth Services published a report finding that it should be legal for telehealth providers to prescribe certain medications for mental health and substance use disorders without requiring an in-person visit. Data from 2023 [...]

pbrown2025-05-04T20:16:01-04:00December 9th, 2024|

Drug and Alcohol Dependence: Patient and Provider Experiences with Opioid Use Disorder Care Delivered Via Telehealth

Drug and Alcohol Dependence: Patient and Provider Experiences with Opioid Use Disorder Care Delivered Via Telehealth Since the onset of the COVID-19 pandemic and loosening of some opioid use disorder (OUD) treatment regulations in the U.S., there has been a rapid rise in the use of telehealth for buprenorphine induction, maintenance, and counseling (tele-bupe). [...]

pbrown2025-05-04T20:24:08-04:00December 4th, 2024|

Telemedicine and e-Health: The Association Between Telehealth Use During Buprenorphine Treatment for Opioid Use Disorder and Clinical Outcomes: A Retrospective Cohort Study

Telemedicine and e-Health: The Association Between Telehealth Use During Buprenorphine Treatment for Opioid Use Disorder and Clinical Outcomes: A Retrospective Cohort Study Patients with opioid use disorder (OUD) represent a high-risk population due to increased rates of adverse health outcomes and death. In this retrospective cohort study within the Veterans Health Administration, telehealth use [...]

pbrown2025-05-04T19:54:35-04:00November 25th, 2024|

Drug and Alcohol Dependence Journal: Factors Associated with Medications for Opioid Use Disorder (MOUD) Treatment Success During Pregnancy Periods

Drug and Alcohol Dependence Journal: Factors Associated with Medications for Opioid Use Disorder (MOUD) Treatment Success During Pregnancy Periods Medications for opioid use disorder (MOUD) are a crucial intervention for pregnant and postpartum individuals with opioid use disorder (OUD). This review evaluated factors associated with MOUD success during the pregnancy and postpartum period and found [...]

pbrown2025-04-06T21:01:47-04:00October 3rd, 2024|

Journal of Substance User & Addiction Treatment: Buprenorphine Discontinuation in Telehealth-Only Treatment for Opioid Use Disorder

Journal of Substance User & Addiction Treatment: Buprenorphine Discontinuation in Telehealth-Only Treatment for Opioid Use Disorder At the beginning of the COVID-19 pandemic, federal agencies permitted telehealth initiation of buprenorphine treatment for opioid use disorder (OUD) without in-person assessment. This longitudinal cohort analysis found that a telehealth-only platform reduced risk of buprenorphine discontinuation compared [...]

pbrown2025-04-06T21:14:11-04:00September 25th, 2024|

JAMA Network Open: Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022

JAMA Network Open: Stimulant, Antidepressant, and Opioid Telehealth Prescription Trends Between 2019 and 2022 This cross-sectional study found that increasing telehealth utilization across medications suggests a growing acceptance, need, or preference for remote services. Opioid prescriptions declined before Q2 of 2020 and continued to decrease by 17.2% from 2019 to 2022. In-person visits accounted [...]

pbrown2025-04-06T20:50:54-04:00September 13th, 2024|

Center for Health Care Strategies: Telehealth and Medications for Opioid Use Disorder: Evidence Roundup

Center for Health Care Strategies: Telehealth and Medications for Opioid Use Disorder: Evidence Roundup In the face of an overwhelming overdose crisis, largely driven by the rise in the synthetic opioid fentanyl, telehealth for MOUD treatment promises to benefit many people. Currently, prescription volumes for MOUD are low and certain under-resourced communities experience significant [...]

pbrown2025-03-05T15:37:17-04:00May 29th, 2024|

Epic Research: ADHD Medications Prescribed at Similar Rates During Telehealth and In-Person Visits

Epic Research: ADHD Medications Prescribed at Similar Rates During Telehealth and In-Person Visits This study analyzed medication prescribing rates for telehealth and office visits, which found that attention deficit hyperactivity disorder (ADHD) medications were prescribed at similar rates during telehealth and in-person visits. Most initial ADHD prescriptions were for stimulant medications in both telehealth (84 [...]

Alliance for Connected Care2023-11-27T18:22:28-04:00June 27th, 2023|

Thank you for signing up!